Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine.
Barroso L, Abhyankar M, Noor Z, Read K, Pedersen K, White R, Fox C, Petri WA Jr, Lyerly D.
Vaccine. 2014 Feb 26;32(10):1218-24. doi: 10.1016/j.vaccine.2013.06.056. Epub 2013 Jul 1.
Characterization of the ligand binding pocket of the virulence regulator Rns, a member of the AraC/XylS family of transcription factors.
Tolbert JD, Talbot KM, Bollinger CM, Kull FJ, Munson GP, Midgett CR.
mSphere. 2025 Aug 26;10(8):e0011525. doi: 10.1128/msphere.00115-25. Epub 2025 Jul 24.
Designing of a chimeric protein contains StxB, intimin and EscC against toxicity and adherence of enterohemorrhagic Escherichia coli O157:H7 and evaluation of serum antibody titers against it.
Sadri Najafabadi Z, Nazarian S, Kargar M, Kafilzadeh F.
Mol Immunol. 2021 Jun;134:218-227. doi: 10.1016/j.molimm.2021.03.016. Epub 2021 Apr 3.
Quantitative resistance level (MIC) of Escherichia coli isolated from calves and pigs suffering from enteritis: national resistance monitoring by the BVL.
Schröer U, Kaspar H, Wallmann J.
Berl Munch Tierarztl Wochenschr. 2007 Sep-Oct;120(9-10):431-41.
Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function.
Zareie M, Riff J, Donato K, McKay DM, Perdue MH, Soderholm JD, Karmali M, Cohen MB, Hawkins J, Sherman PM.
Cell Microbiol. 2005 Dec;7(12):1782-97. doi: 10.1111/j.1462-5822.2005.00595.x.
[Isolation of Shiga-toxin-producing Escherichia coli strains during a gastrointestinal outbreak at a day care center in Mar del Plata City].
Gomez D, Miliwebsky E, Silva A, Deza N, Zotta C, Cotella O, Martínez Espinosa E, Chinen I, Fernández Pascua C, Rivas M.
Rev Argent Microbiol. 2005 Oct-Dec;37(4):176-83.
